Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N H Mulder

Showing results (301-310 of 369) with videos related to

Pageof 37
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 23, 2004
Treatment of locally recurrent rectal cancer, results and prognostic factorsO Reerink, N H Mulder, G Botke, et al.
International Journal of Cancer|June 19, 1991
In vitro and in vivo modulation of multi-drug resistance with amiodaroneW T van der Graaf, E G de Vries, D R Uges, et al.
The Netherlands Journal of Medicine|January 1, 1984
Feasibility of high dose VP 16-213 as single agent or in combination with cyclophosphamide and autologous bone marrow transplantation (ABMT)N H Mulder, A F Meinesz, D T Sleijfer, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Changes in pulmonary function during and after bleomycin treatment in patients with testicular carcinomaP W van Barneveld, G Veenstra, D T Sleijfer, et al.
International Journal of Cancer|April 9, 1998
Transport of glutathione conjugates into secretory vesicles is mediated by the multidrug-resistance protein 1M J Van Luyn, M Müller, J Renes, et al.
European Journal of Cancer (Oxford, England : 1990)|April 28, 2004
Factors influencing haematological recovery following high-dose chemotherapy and peripheral stem-cell transplantation for haematological malignancies; 1-year analysisP Nieboer, E G E de Vries, E Vellenga, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1993
HLA-Dr-expressing CD8bright cells are only temporarily present in the circulation during subcutaneous recombinant interleukin-2 therapy in renal cell carcinoma patientsR A Janssen, J Buter, E Straatsma, et al.
Cancer|April 3, 2001
Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin eraD J Sonneveld, H J Hoekstra, W T van der Graaf, et al.
Cancer Research|December 1, 1988
Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitroG A Hospers, N H Mulder, B de Jong, et al.
Cancer|March 1, 1995
5-Fluorouracil/leucovorin/interferon alpha-2a in patients with advanced colorectal cancer. Effects of maintenance therapy on remission durationJ Buter, H A Sinnige, D T Sleijfer, et al.
Pageof 37

Showing results (301-310 of 369) with videos related to

Sort By:
Pageof 37
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 23, 2004
Treatment of locally recurrent rectal cancer, results and prognostic factorsO Reerink, N H Mulder, G Botke, et al.
International Journal of Cancer|June 19, 1991
In vitro and in vivo modulation of multi-drug resistance with amiodaroneW T van der Graaf, E G de Vries, D R Uges, et al.
The Netherlands Journal of Medicine|January 1, 1984
Feasibility of high dose VP 16-213 as single agent or in combination with cyclophosphamide and autologous bone marrow transplantation (ABMT)N H Mulder, A F Meinesz, D T Sleijfer, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Changes in pulmonary function during and after bleomycin treatment in patients with testicular carcinomaP W van Barneveld, G Veenstra, D T Sleijfer, et al.
International Journal of Cancer|April 9, 1998
Transport of glutathione conjugates into secretory vesicles is mediated by the multidrug-resistance protein 1M J Van Luyn, M Müller, J Renes, et al.
European Journal of Cancer (Oxford, England : 1990)|April 28, 2004
Factors influencing haematological recovery following high-dose chemotherapy and peripheral stem-cell transplantation for haematological malignancies; 1-year analysisP Nieboer, E G E de Vries, E Vellenga, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1993
HLA-Dr-expressing CD8bright cells are only temporarily present in the circulation during subcutaneous recombinant interleukin-2 therapy in renal cell carcinoma patientsR A Janssen, J Buter, E Straatsma, et al.
Cancer|April 3, 2001
Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin eraD J Sonneveld, H J Hoekstra, W T van der Graaf, et al.
Cancer Research|December 1, 1988
Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitroG A Hospers, N H Mulder, B de Jong, et al.
Cancer|March 1, 1995
5-Fluorouracil/leucovorin/interferon alpha-2a in patients with advanced colorectal cancer. Effects of maintenance therapy on remission durationJ Buter, H A Sinnige, D T Sleijfer, et al.
Pageof 37